Cargando…

Tracking SARS-CoV-2 seroprevalence among Canadian blood donors

Detalles Bibliográficos
Autores principales:	Saeed, Sahar, Drews, Steven, Pambrun, Chantale, Yi, Qi-Long, Osmond, Lori, O'Brien, Sheila
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Inc. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8883598/ http://dx.doi.org/10.1016/j.tmrv.2021.10.007

Ejemplares similares

SARS-CoV-2 Seroprevalence among Canadian Blood Donors: The Advance of Omicron
por: O’Brien, Sheila F., et al.
Publicado: (2022)

Changing Patterns of SARS-CoV-2 Seroprevalence among Canadian Blood Donors during the Vaccine Era
por: Reedman, Cassandra N., et al.
Publicado: (2022)

Cross-Canada Variability in Blood Donor SARS-CoV-2 Seroprevalence by Social Determinants of Health
por: O’Brien, Sheila F., et al.
Publicado: (2023)

SARS-CoV-2 Seroprevalence in the Vaccine Era: The Canadian Blood Services Serosurvey January to November 2021
por: O'Brien, Sheila, et al.
Publicado: (2023)

Estimating SARS-CoV-2 Seroprevalence in Canadian Blood Donors, April 2020 to March 2021: Improving Accuracy with Multiple Assays
por: Tuite, Ashleigh R., et al.
Publicado: (2022)

SARS-CoV-2 Virus-Like Particle Neutralizing Capacity in Blood Donors Depends on Serological Profile and Donor-Declared SARS-CoV-2 Vaccination History
por: Drews, Steven J., et al.
Publicado: (2022)

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence: Navigating the absence of a gold standard
por: Saeed, Sahar, et al.
Publicado: (2021)

Resistance of SARS‐CoV‐2 beta and gamma variants to plasma collected from Canadian blood donors during the spring of 2020
por: Drews, Steven J., et al.
Publicado: (2021)

Hepatitis B Blood Donor Screening Data: An Under-Recognized Resource for Canadian Public Health Surveillance
por: O’Brien, Sheila F., et al.
Publicado: (2023)

An expanded role for blood donor emerging pathogens surveillance
por: O’Brien, Sheila F., et al.
Publicado: (2023)

A Qualitative Comparison of the Abbott SARS-CoV-2 IgG II Quant Assay against Commonly Used Canadian SARS-CoV-2 Enzyme Immunoassays in Blood Donor Retention Specimens, April 2020 to March 2021
por: Abe, Kento T., et al.
Publicado: (2022)

A Prospective Observational Cohort Comparison of SARS-CoV-2 Seroprevalence Between Paramedics and Matched Blood Donors in Canada During the COVID-19 Pandemic
por: Grunau, Brian, et al.
Publicado: (2022)

Loss of repeat convalescent plasma donors due to waning anti-SARS-CoV-2 plaque reduction neutralization test titers (April-December 2020)
por: Drews, Steven, et al.
Publicado: (2022)

The evolution of SARS-CoV-2 seroprevalence in Canada: a time-series study, 2020–2023
por: Murphy, Tanya J., et al.
Publicado: (2023)

Vaccination and SARS-CoV-2 seroprevalence in blood donors: Correspondence
por: Sookaromdee, Pathum, et al.
Publicado: (2023)

SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood
por: Ng, Dianna L., et al.
Publicado: (2020)

The estimated risk of SARS-CoV- 2 infection via cornea transplant in Canada
por: O’Brien, Sheila F., et al.
Publicado: (2021)

Seroprevalence of anti-SARS-CoV-2 among blood donors in Rio de Janeiro, Brazil
por: Amorim, Luiz, et al.
Publicado: (2020)

Diminished Neutralization Capacity of SARS-CoV-2 Omicron BA.1 in Donor Plasma Collected from January to March 2021
por: Lin, Yi-Chan J., et al.
Publicado: (2023)

Seroprevalence of ancestral and Beta SARS-CoV-2 antibodies in Malagasy blood donors
por: Razafimahatratra, Solohery Lalaina, et al.
Publicado: (2021)

Seroprevalence of SARS-CoV-2 antibodies in 2115 blood donors from Romania
por: Olariu, Tudor Rares, et al.
Publicado: (2021)

Long-Term SARS-CoV-2 Antibody Seroprevalence in Blood Donors, Italy
por: Ferrari, Martina, et al.
Publicado: (2023)

Lessons Learned from the COVID-19 Pandemic and How Blood Operators Can Prepare for the Next Pandemic
por: Drews, Steven J., et al.
Publicado: (2022)

Seroprevalence of SARS-CoV-2 antibodies among healthy blood donors in Karachi, Pakistan
por: Younas, Amber, et al.
Publicado: (2020)

Seroprevalence of anti–SARS-CoV-2 IgG antibodies in Kenyan blood donors
por: Uyoga, Sophie, et al.
Publicado: (2021)

Infection-Induced SARS-CoV-2 Seroprevalence among Blood Donors, Japan, 2022
por: Kinoshita, Ryo, et al.
Publicado: (2023)

Seroprevalence of antibodies to SARS-CoV-2 among blood donors in the early months of the pandemic in Saudi Arabia
por: Banjar, Ayman, et al.
Publicado: (2021)

SARS‐CoV‐2 antibody seroprevalence rates among Egyptian blood donors around the third wave: Cross‐sectional study
por: Eldesoukey, Nermeen, et al.
Publicado: (2022)

Low SARS-CoV-2 seroprevalence in blood donors in the early COVID-19 epidemic in the Netherlands
por: Slot, Ed, et al.
Publicado: (2020)

Seroprevalence of anti-SARS-CoV-2 total antibody is higher in younger Austrian blood donors
por: Weidner, Lisa, et al.
Publicado: (2021)

SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood from the San Francisco Bay Area
por: Ng, Dianna L., et al.
Publicado: (2020)

Canadian SARS-CoV-2 serological survey using antenatal serum samples: a retrospective seroprevalence study
por: Atkinson, Andrea, et al.
Publicado: (2023)

The seroprevalence of SARS-CoV-2 IgG antibodies among asymptomatic blood donors in Saudi Arabia
por: Mahallawi, Waleed H., et al.
Publicado: (2021)

Seroprevalence of SARS-CoV-2 antibodies in blood donors during the third wave of infection in Campeche Mexico
por: Monteón, Victor, et al.
Publicado: (2022)

Seroprevalence of SARS-CoV-2 Antibodies Among Blood Donors in Malaysia During the Pre-Vaccination Period
por: Shukri, A.M.A., et al.
Publicado: (2022)

Seroprevalence of SARS-CoV-2 among blood donors: A practical serosurveillance tool for COVID-19
por: Bansal, N., et al.
Publicado: (2022)

Impact of vaccination on SARS-CoV-2 seroprevalence rate in French blood donors: An assessment as of July 2021
por: Gallian, Pierre, et al.
Publicado: (2023)

Sensitivity of the Elecsys Nucleocapsid Assay for the Detection of Preceding SARS-CoV-2 Infections
por: Grunau, Brian, et al.
Publicado: (2022)

Seroprevalence of anti-SARS-CoV-2 antibodies and risk factors among healthy blood donors in Luanda, Angola
por: Sebastião, Cruz S., et al.
Publicado: (2021)

SARS-CoV-2 seroprevalence among blood donors, Chongqing, China, January 1 to May 31, 2020
por: Wang, Shichun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fmp8b2co64t1mou6itp9oc9tg3